Unknown

Dataset Information

Temozolomide sensitivity of malignant glioma cell lines - a systematic review assessing consistencies between in vitro studies.


ABSTRACT:

Background

Malignant glioma cell line models are integral to pre-clinical testing of novel potential therapies. Accurate prediction of likely efficacy in the clinic requires that these models are reliable and consistent. We assessed this by examining the reporting of experimental conditions and sensitivity to temozolomide in glioma cells lines.

Methods

We searched Medline and Embase (Jan 1994-Jan 2021) for studies evaluating the effect of temozolomide monotherapy on cell viability of at least one malignant glioma cell line. Key data items included type of cell lines, temozolomide exposure duration in hours (hr), and cell viability measure (IC50).

Results

We included 212 studies from 2789 non-duplicate records that reported 248 distinct cell lines. The commo

SUBMITTER: Poon MTC 

PROVIDER: S-EPMC8600737 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature